Get started
Author

Lori A. Schretzman

Observed names: L. A. SCHRETZMAN, Lori A Schretzman, Lori Schretzman
OpenAlex ID: A5089868569
Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor
1993 · Jeffery A. Zablocki, Masateru Miyano, et al. · Journal of Medicinal Chemistry · 106
Potent in Vitro and in Vivo Inhibitors of Platelet Aggregation Based Upon the Arg-Gly-Asp Sequence of Fibrinogen. (Aminobenzamidino)succinyl (ABAS) Series of Orally Active Fibrinogen Receptor Antagonists
1995 · Jeffery A. Zablocki, Joseph G. Rico, et al. · Journal of Medicinal Chemistry · 103
Convergent, parallel synthesis of a series of β-substituted 1,2,4-oxadiazole butanoic acids as potent and selective αvβ3 receptor antagonists
2005 · Mark L. Boys, Lori A. Schretzman, et al. · Bioorganic & Medicinal Chemistry Letters · 48
Inhibition of human cytomegalovirus protease by benzoxazinones and evidence of antiviral activity in cell culture
1997 · Norman A. Abood, Lori A Schretzman, et al. · Bioorganic & Medicinal Chemistry Letters · 47
A novel series of orally active antiplatelet agents
1995 · Jeffery A. Zablocki, Foe S. Tjoeng, et al. · Bioorganic & Medicinal Chemistry · 32
ChemInform Abstract: Inhibition of Human Cytomegalovirus Protease by Benzoxazinones and Evidence of Antiviral Activity in Cell Culture.
1997 · N. A. ABOOD, L. A. SCHRETZMAN, et al. · ChemInform
Works count: 6
Citation count: 336
H-index: 5
I10-index: 5
Year
Topic
Type